TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy

In this study, we investigated the association between TP53 somatic mutations and immunotherapeutic outcomes in non-small cell lung cancer (NSCLC) patients. Kaplan-Meier survival curve analysis of the MSK-IMPACT cohort of 350 NSCLC patients shows that overall survival (OS) is significantly lower for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Liqin, Qu, Xiaofei, Wu, Zhenhua, Li, Yuehua, Zhang, Xiaowei, Guo, WeiJian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425464/
https://www.ncbi.nlm.nih.gov/pubmed/32694238
http://dx.doi.org/10.18632/aging.103502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425464/
https://www.ncbi.nlm.nih.gov/pubmed/32694238
http://dx.doi.org/10.18632/aging.103502

Ejemplares similares